VR Logo

Suven Pharmaceuticals: Announcement under Regulation 30 (LODR)-Cessation


Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) read with Para A of Part A of Schedule III to the Listing Regulations we wish to inform that Dr. Chandrasekhar Srivari (DIN: 00481481) has resigned from the position of the Non-executive Independent Director of the Company with effective from January 19 2022 due to new appointment as Secretary Department of Science and Technology Govt. of India New Delhi. Further please find below requisite disclosures as per Regulation 30 read with Para A of Part A of Schedule III to the Listing Regulations as amended from time to time:

Click here to view PDF